Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?

Neurology. 2007 Oct 9;69(15):1478-9. doi: 10.1212/01.wnl.0000275545.08382.82.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Bias
  • Clinical Protocols / standards
  • Cohort Studies
  • Data Interpretation, Statistical
  • Databases as Topic / standards*
  • Databases as Topic / statistics & numerical data
  • Disability Evaluation
  • Disease Progression
  • Humans
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / epidemiology*
  • Randomized Controlled Trials as Topic / standards*
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Recurrence
  • Reproducibility of Results
  • Time
  • Treatment Outcome

Substances

  • Antirheumatic Agents